Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominika Nowis

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
International Journal of Oncology|November 6, 2007
Erythropoietin reduces cisplatin-induced neurotoxicity without impairment of cytotoxic effects against tumor cellsDominika Nowis, Magdalena Legat, Jacek Bil, et al.
Cardiovascular Research|September 19, 2025
Impaired coronary flow reserve by hyperviscosity in a mouse model of non-light chain multiple myeloma: a mechanism of coronary flow impairment at the capillary levelAleksandra Paterek, Filip Rolski, Mateusz Surzykiewicz, et al.
Cancer Letters|March 13, 2021
Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitorsMonika K Prelowska, Dawid Mehlich, M Talha Ugurlu, et al.
Cancer Letters|December 7, 2021
Corrigendum to "Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors" [Canc. Lett. 507 (2021) 13-25]Monika K Prelowska, Dawid Mehlich, M Talha Ugurlu, et al.
Nature Communications|September 22, 2017
The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myelomaSeweryn Mroczek, Justyna Chlebowska, Tomasz M Kuliński, et al.
International Journal of Oncology|December 22, 2007
Ciglitazone, an agonist of peroxisome proliferator-activated receptor gamma, exerts potentiated cytostatic/cytotoxic effects against tumor cells when combined with lovastatinPiotr Mrówka, Eliza Glodkowska, Dominika Nowis, et al.
International Journal of Cancer|February 22, 2002
Potentiating antitumor effects of a combination therapy with lovastatin and butyrate in the Lewis lung carcinoma model in miceAdam Giermasz, Marcin Makowski, Ewa Kozłowska, et al.
BMC Cancer|July 16, 2008
Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in miceDominika Nowis, Marek Bugajski, Magdalena Winiarska, et al.
Genome Biology|May 17, 2023
Celloscope: a probabilistic model for marker-gene-driven cell type deconvolution in spatial transcriptomics dataAgnieszka Geras, Shadi Darvish Shafighi, Kacper Domżał, et al.
Journal of Neuropathology and Experimental Neurology|September 3, 2017
Bortezomib-Induced Muscle Toxicity in Multiple MyelomaValeria Guglielmi, Dominika Nowis, Martina Tinelli, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
International Journal of Oncology|November 6, 2007
Erythropoietin reduces cisplatin-induced neurotoxicity without impairment of cytotoxic effects against tumor cellsDominika Nowis, Magdalena Legat, Jacek Bil, et al.
Cardiovascular Research|September 19, 2025
Impaired coronary flow reserve by hyperviscosity in a mouse model of non-light chain multiple myeloma: a mechanism of coronary flow impairment at the capillary levelAleksandra Paterek, Filip Rolski, Mateusz Surzykiewicz, et al.
Cancer Letters|March 13, 2021
Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitorsMonika K Prelowska, Dawid Mehlich, M Talha Ugurlu, et al.
Cancer Letters|December 7, 2021
Corrigendum to "Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors" [Canc. Lett. 507 (2021) 13-25]Monika K Prelowska, Dawid Mehlich, M Talha Ugurlu, et al.
Nature Communications|September 22, 2017
The non-canonical poly(A) polymerase FAM46C acts as an onco-suppressor in multiple myelomaSeweryn Mroczek, Justyna Chlebowska, Tomasz M Kuliński, et al.
International Journal of Oncology|December 22, 2007
Ciglitazone, an agonist of peroxisome proliferator-activated receptor gamma, exerts potentiated cytostatic/cytotoxic effects against tumor cells when combined with lovastatinPiotr Mrówka, Eliza Glodkowska, Dominika Nowis, et al.
International Journal of Cancer|February 22, 2002
Potentiating antitumor effects of a combination therapy with lovastatin and butyrate in the Lewis lung carcinoma model in miceAdam Giermasz, Marcin Makowski, Ewa Kozłowska, et al.
BMC Cancer|July 16, 2008
Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in miceDominika Nowis, Marek Bugajski, Magdalena Winiarska, et al.
Genome Biology|May 17, 2023
Celloscope: a probabilistic model for marker-gene-driven cell type deconvolution in spatial transcriptomics dataAgnieszka Geras, Shadi Darvish Shafighi, Kacper Domżał, et al.
Journal of Neuropathology and Experimental Neurology|September 3, 2017
Bortezomib-Induced Muscle Toxicity in Multiple MyelomaValeria Guglielmi, Dominika Nowis, Martina Tinelli, et al.
Pageof 10